This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Edgewell Personal (EPC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Edgewell Personal (EPC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Kimberly-Clark Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Kimberly-Clark's (KMB) robust cost-saving efforts bode well. Further, the company is on track with e-commerce growth and expansion in developing markets.
Consumer Products Industry Players Bank on Buyouts & Innovation
by Vrishali Bagree
Consumer product players are focused on chalking out revenue-boosting initiatives to squeeze out more from their operations. Competition from cheaper alternatives is a concern.
Edgewell Personal Care (EPC) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of 68.18% and 2.60%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Edgewell Personal Care (EPC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Edgewell Personal (EPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for November 15th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Edgewell Personal Care (EPC) Q4 Earnings Top Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of 2.78% and -3.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Edgewell Personal Care (EPC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Edgewell Personal (EPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Edgewell Personal Care (EPC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of 18.18% and 0.86%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Zagg, Edgewell Personal Care and Harley-Davidson highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Zagg, Edgewell Personal Care and Harley-Davidson highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Edgewell Personal Care (EPC)
by Madeleine Johnson
Disappointing guidance and weak North American sales are dragging this stock down.
New Strong Sell Stocks for May 8th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
Why Earnings Season Could Be Great for Edgewell Personal Care (EPC)
by Zacks Equity Research
Edgewell Personal Care (EPC) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Monster Beverage (MNST) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Monster Beverage's (MNST) second-quarter results are likely to benefit from higher demand for its energy drink brands.
Should You Buy Energizer Holdings, Inc. (EPC) Ahead of Earnings?
by Zacks Equity Research
Given that Energizer Holdings, Inc. (EPC) has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings.
5 Factors That Make Newell (NWL) a Viable Investment Choice
by Zacks Equity Research
Newell Brands (NWL) appears to be a sound bet, given its solid bull run that is backed by its spectacular earnings history, favorable estimate revisions, superb growth strategies and shareholder-friendly moves.
Consumer Staples Stocks' Earnings on May 2: MO, SPB and EPC
by Zacks Equity Research
Let's see what awaits the following Consumer Staples stocks that are queued up for earnings releases on May 2.
Clorox (CLX) in Troubled Waters: What's Hurting the Stock?
by Zacks Equity Research
Clorox (CLX), which had sort of settled in the green territory, has seen its shares slide recently.
New Strong Buy Stocks for December 12th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Newell's (NWL) Strategic Growth on Track: Should You Add?
by Zacks Equity Research
Newell (NWL) has been doing well with its new Growth Game Plan, Project Renewal Program and solid earnings track record.
Top Ranked Momentum Stocks to Buy for November 30th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, November 30th:
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma
by Zacks Equity Research
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma
New Strong Buy Stocks for November 28th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
The Zacks Analyst Blog Highlights: Best Buy, Edgewell Personal Care and Eagle Pharma
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Best Buy, Edgewell Personal Care and Eagle Pharma
New Strong Buy Stocks for November 16th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday